Accelerator Corporation (formerly XORI) is a vehicle for capital-efficient investment in and management of emerging biotechnology opportunities. Formed by a syndicate of top-tier venture capital investors and supported by a consortium of world-class research institutions, Accelerator identifies, evaluates, finances, and manages the commercialization of technologies and assets sourced from a broad range of proprietary sources.